Last updated on November 2019

A Study of the Efficacy and Safety of Upadacitnib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies


Brief description of study

The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and severely active Crohn's disease (CD).

Clinical Study Identifier: NCT03345849

Find a site near you

Start Over

Allergy & Immunology (AIU) /ID# 171431

Cape Town, South Africa
2.02miles
  Connect »

Dr JP Wright /ID# 170887

Cape Town, South Africa
3.57miles
  Connect »

Mediclinic Constantiaberg /ID# 169853

Cape Town, South Africa
5.05miles
  Connect »